BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caputi FF, Rullo L, Stamatakos S, Candeletti S, Romualdi P. Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions. Int J Mol Sci 2019;20:E4010. [PMID: 31426473 DOI: 10.3390/ijms20164010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Caputi FF, Stopponi S, Rullo L, Palmisano M, Ubaldi M, Candeletti S, Ciccocioppo R, Romualdi P. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats. Int J Mol Sci 2021;22:2448. [PMID: 33671048 DOI: 10.3390/ijms22052448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nazarian A, Negus SS, Martin TJ. Factors mediating pain-related risk for opioid use disorder. Neuropharmacology 2021;186:108476. [PMID: 33524407 DOI: 10.1016/j.neuropharm.2021.108476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Elia G, Mayors Woods LE, Pantilat SZ. End of life care for patients with meningioma. Handb Clin Neurol 2020;170:333-48. [PMID: 32586506 DOI: 10.1016/B978-0-12-822198-3.00052-5] [Reference Citation Analysis]
4 Delery EC, Edwards S. Neuropeptide and cytokine regulation of pain in the context of substance use disorders. Neuropharmacology 2020;174:108153. [PMID: 32470337 DOI: 10.1016/j.neuropharm.2020.108153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Langford DJ, Eaton L, Kober KM, Paul SM, Cooper BA, Hammer MJ, Conley YP, Wright F, Dunn LB, Levine JD, Miaskowski C. A high stress profile is associated with severe pain in oncology patients receiving chemotherapy. Eur J Oncol Nurs 2022;58:102135. [PMID: 35366425 DOI: 10.1016/j.ejon.2022.102135] [Reference Citation Analysis]